Annual Non Current Assets
$43.10 K
+$8200.00+23.50%
31 December 2023
Summary:
Relmada Therapeutics annual long term assets is currently $43.10 thousand, with the most recent change of +$8200.00 (+23.50%) on 31 December 2023. During the last 3 years, it has fallen by -$69.50 thousand (-61.72%). RLMD annual non current assets is now -95.44% below its all-time high of $945.70 thousand, reached on 30 June 2016.RLMD Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$22.00 K
-$31.60 K-58.96%
30 September 2024
Summary:
Relmada Therapeutics quarterly long term assets is currently $22.00 thousand, with the most recent change of -$31.60 thousand (-58.96%) on 30 September 2024. Over the past year, it has dropped by -$25.70 thousand (-53.88%). RLMD quarterly non current assets is now -97.69% below its all-time high of $950.60 thousand, reached on 30 September 2016.RLMD Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RLMD Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.5% | -53.9% |
| 3 y3 years | -61.7% | -53.5% |
| 5 y5 years | -81.7% | -89.8% |
RLMD Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.7% | +52.3% | -59.0% | +36.6% |
| 5 y | 5 years | -81.7% | +52.3% | -89.8% | +36.6% |
| alltime | all time | -95.4% | -97.7% |
Relmada Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.00 K(-59.0%) |
| June 2024 | - | $53.60 K(+24.4%) |
| Mar 2024 | - | $43.10 K(0.0%) |
| Dec 2023 | $97.51 M(-36.2%) | $43.10 K(-9.6%) |
| Sept 2023 | - | $47.70 K(+37.9%) |
| June 2023 | - | $34.60 K(-0.9%) |
| Mar 2023 | - | $34.90 K(0.0%) |
| Dec 2022 | $152.87 M(-31.5%) | $34.90 K(+116.8%) |
| Sept 2022 | - | $16.10 K(-54.3%) |
| June 2022 | - | $35.20 K(+24.4%) |
| Mar 2022 | - | $28.30 K(0.0%) |
| Dec 2021 | $223.30 M(+89.1%) | $28.30 K(-40.2%) |
| Sept 2021 | - | $47.30 K(-31.5%) |
| June 2021 | - | $69.10 K(-24.0%) |
| Mar 2021 | - | $90.90 K(-19.3%) |
| Dec 2020 | $118.07 M(+1.0%) | $112.60 K(-15.9%) |
| Sept 2020 | - | $133.90 K(-13.6%) |
| June 2020 | - | $154.90 K(-11.8%) |
| Mar 2020 | - | $175.60 K(-18.6%) |
| Dec 2019 | $116.94 M(+1071.2%) | - |
| Sept 2019 | - | $215.80 K(-8.3%) |
| June 2019 | $9.98 M | $235.40 K(-13.9%) |
| Mar 2019 | - | $273.40 K(+2.3%) |
| Dec 2018 | - | $267.20 K(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $285.80 K(-7.8%) |
| June 2018 | $2.74 M(+10.6%) | $310.10 K(-1.5%) |
| Mar 2018 | - | $314.70 K(-5.2%) |
| Dec 2017 | - | $331.90 K(-4.7%) |
| Sept 2017 | - | $348.40 K(-3.8%) |
| June 2017 | $2.47 M(-73.4%) | $362.00 K(-60.9%) |
| Mar 2017 | - | $926.80 K(-0.3%) |
| Dec 2016 | - | $929.70 K(-2.2%) |
| Sept 2016 | - | $950.60 K(+0.5%) |
| June 2016 | $9.30 M(-61.2%) | $945.70 K(+0.4%) |
| Mar 2016 | - | $942.40 K(-0.6%) |
| Dec 2015 | - | $948.50 K(+118.4%) |
| Sept 2015 | - | $434.20 K(+2.2%) |
| June 2015 | $23.97 M(-6.9%) | $424.70 K(+1099.7%) |
| Mar 2015 | - | $35.40 K(-0.6%) |
| Dec 2014 | - | $35.60 K(+22.8%) |
| Sept 2014 | - | $29.00 K(+2130.8%) |
| June 2014 | $25.74 M(>+9900.0%) | - |
| Feb 2014 | - | $1300.00(-7.1%) |
| Nov 2013 | - | $1400.00(-6.7%) |
| Aug 2013 | $18.50 K(+0.5%) | $1500.00(-11.8%) |
| May 2013 | - | $1700.00(>+9900.0%) |
| Feb 2013 | - | $0.00(0.0%) |
| Aug 2012 | $18.40 K | $0.00 |
FAQ
- What is Relmada Therapeutics annual long term assets?
- What is the all time high annual non current assets for Relmada Therapeutics?
- What is Relmada Therapeutics annual non current assets year-on-year change?
- What is Relmada Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly non current assets year-on-year change?
What is Relmada Therapeutics annual long term assets?
The current annual non current assets of RLMD is $43.10 K
What is the all time high annual non current assets for Relmada Therapeutics?
Relmada Therapeutics all-time high annual long term assets is $945.70 K
What is Relmada Therapeutics annual non current assets year-on-year change?
Over the past year, RLMD annual long term assets has changed by +$8200.00 (+23.50%)
What is Relmada Therapeutics quarterly long term assets?
The current quarterly non current assets of RLMD is $22.00 K
What is the all time high quarterly non current assets for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly long term assets is $950.60 K
What is Relmada Therapeutics quarterly non current assets year-on-year change?
Over the past year, RLMD quarterly long term assets has changed by -$25.70 K (-53.88%)